Year archive

Cipla Ltd. — 2024 filings

All 327 regulatory filings released by Cipla Ltd. (CIPLA) in 2024, sourced directly from the official regulator.

327 Filings

2024 Period

2024 filings (327)

Filing	Released	Lang
Intimation under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-12-20	English
Action(s) initiated or orders passed Regulatory Filings	2024-12-20	English
In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the Operations and Administrative Committee .... Regulatory Filings	2024-12-05	English
ESOP/ESOS/ESPS Regulatory Filings	2024-12-05	English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-12-02	English
Action(s) initiated or orders passed Regulatory Filings	2024-12-02	English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Samina Hamied & Others Regulatory Filings	2024-12-02	English
General Updates Regulatory Filings	2024-11-30	English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-11-30	English
Action(s) initiated or orders passed Regulatory Filings	2024-11-28	English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-11-28	English
Updates Regulatory Filings	2024-11-18	English
Disclosure under regulation 30(5) of the SEBI (LODR) Regulations, 2015 Regulatory Filings	2024-11-18	English
In compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the Operations and Administration Committee of the Company .... Regulatory Filings	2024-11-15	English
ESOP/ESOS/ESPS Regulatory Filings	2024-11-15	English
USFDA inspection at Company''s manufacturing facility in Virgonagar, Bengaluru, India Regulatory Filings	2024-11-13	English
Updates Regulatory Filings	2024-11-13	English
Change in Director(s) Regulatory Filings	2024-11-12	English
Ms Punita Lal is completing her second term as an independent director on 12th November 2024 Regulatory Filings	2024-11-12	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-11-02	English
We are enclosing herewith copy of the transcript of the Company''s Q2FY25 earnings conference call held on 29th October, 2024. Regulatory Filings	2024-11-02	English
General Updates Regulatory Filings	2024-10-30	English
Update on USFDA inspection at Company''s manufacturing facility in Goa, India Regulatory Filings	2024-10-30	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-10-29	English
Pursuant to Regulation 30(6) of the SEBI 9Listing Obligations and Disclosure) Requirements, 2015, the audio recording of the earnings conference call for Q1FY25 held today is available .... Regulatory Filings	2024-10-29	English
Please find the attached newspaper publication Regulatory Filings	2024-10-29	English
Copy of Newspaper Publication Regulatory Filings	2024-10-29	English
Outcome of Board meeting dated 29th October 2024 Regulatory Filings	2024-10-29	English
Outcome of Board Meeting Regulatory Filings	2024-10-29	English
Investor Presentation Regulatory Filings	2024-10-29	English
Please find the attached investor presentation dated 29th October 2024 Regulatory Filings	2024-10-29	English
Please find the attached press release dated 29th October 2024 Regulatory Filings	2024-10-29	English
Press Release Regulatory Filings	2024-10-29	English
Unaudited financial results (standalone and consolidated) for the quarter and half year ended 30th September 2024 Regulatory Filings	2024-10-29	English
Financial Result Updates Regulatory Filings	2024-10-29	English
Agreements Regulatory Filings	2024-10-25	English
Update on acquisition of additional equity interest in Cipla (Jiangsu) Pharmaceuticals Co., Ltd. Regulatory Filings	2024-10-25	English
Action(s) taken or orders passed Regulatory Filings	2024-10-17	English
Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI Listing Regulations, 2015'') Regulatory Filings	2024-10-17	English
Result of the Postal Ballot along with Scrutiniser'' report Regulatory Filings	2024-10-14	English
Shareholders meeting Regulatory Filings	2024-10-14	English
Certificate under SEBI (Depositories and Participants) Regulations, 2018 Regulatory Filings	2024-10-11	English
Certificate under Regulation 74(5) of SEBI (DP) Regulation, 2018 Regulatory Filings	2024-10-11	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-10-09	English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the schedule of Earnings .... Regulatory Filings	2024-10-09	English
Options to purchase securities Regulatory Filings	2024-10-05	English
In compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the Operations and Administrative Committee of the Company .... Regulatory Filings	2024-10-05	English
Board Meeting — CIPLA LIMITED has informed the Exchange about Board Meeting to be held on 29-Oct-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarter… Regulatory Filings	2024-10-01	English
Board Meeting — Financial Results Regulatory Filings	2024-10-01	English
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2024 ,inter alia, to consider and approve the unaudited standalone and consolidated .... Regulatory Filings	2024-10-01	English
Intimation under Regulation 30 read with Schedule lll of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-09-25	English
Agreements Regulatory Filings	2024-09-25	English
Newspaper advertisement for Notice of Postal Ballot and e-voting information Regulatory Filings	2024-09-14	English
Copy of Newspaper Publication Regulatory Filings	2024-09-14	English
Shareholders meeting Regulatory Filings	2024-09-13	English
Notice of Postal Ballot dated 3rd September 2024 Regulatory Filings	2024-09-13	English
In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we hereby notify that the Operations and Administrative .... Regulatory Filings	2024-09-12	English
Allotment of Securities Regulatory Filings	2024-09-12	English
Corrigendum - Outcome of Board meeting held on 3rd September 2024 Regulatory Filings	2024-09-03	English
Corrigendum Regulatory Filings	2024-09-03	English
Change in Directors of the Company Regulatory Filings	2024-09-03	English
Change in Director(s) Regulatory Filings	2024-09-03	English
Outcome of Board meeting held on 3rd September 2024 Regulatory Filings	2024-09-03	English
Outcome of Board Meeting Regulatory Filings	2024-09-03	English
Change in Director(s) Regulatory Filings	2024-09-02	English
Mr. Adil Zainulbhai and Mr. Ashok Sinha are completing their second term as an independent director on 2nd September 2024. Regulatory Filings	2024-09-02	English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-08-30	English
Updates Regulatory Filings	2024-08-30	English
Updates Regulatory Filings	2024-08-30	English
Please find enclosed the transcript of the 88th Annual General Meeting of the Company held on Tuesday, 20th August, 2024 through video conferencing/ other audio-visual means. Regulatory Filings	2024-08-30	English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-08-25	English
Updates Regulatory Filings	2024-08-25	English
Shareholders meeting Regulatory Filings	2024-08-20	English
Details of voting results of the 88th Annual General Meeting of the Company and Scrutiniser''s report Regulatory Filings	2024-08-20	English
Change in Management Regulatory Filings	2024-08-20	English
Retirement of Mr. S. Radhakrishnan as Non-Executive Director of the Company Regulatory Filings	2024-08-20	English
Proceedings of the 88th Annual General Meeting. Regulatory Filings	2024-08-20	English
Shareholders meeting Regulatory Filings	2024-08-20	English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company will .... Regulatory Filings	2024-08-20	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-08-20	English
Updates Regulatory Filings	2024-08-19	English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-08-19	English
Further to our intimation dated 3rd August 2024 on the schedule of analyst / institutional investor meeting, we would like to intimate that the mode of meeting for 7th August 2024 with .... Regulatory Filings	2024-08-05	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-08-05	English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein mention the schedule of Analyst / .... Regulatory Filings	2024-08-03	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-08-03	English
In compliance with the provisions of the Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the Operations and the Administrative .... Regulatory Filings	2024-08-02	English
We are enclosing herewith copy of the transcript of the Company''s Q1 FY25 earnings conference call held on 26th July, 2024 Regulatory Filings	2024-07-29	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-07-29	English
Enclosing herewith copies of newspaper advertisement published in Business Standards and Sakal today 27th July 2024. Regulatory Filings	2024-07-27	English
Copy of Newspaper Publication Regulatory Filings	2024-07-27	English
Updates Regulatory Filings	2024-07-26	English
Business Responsibility and Sustainability Report for FY 2023-24 Regulatory Filings	2024-07-26	English
Notice of the 88th Annual General Meeting along with a copy of the Integrated Annual Report for FY 2023-24 Regulatory Filings	2024-07-26	English
Shareholders meeting Regulatory Filings	2024-07-26	English
Notice of the 88th Annual General Meeting along with a copy of the Integrated Annual Report for FY 2023-24 Regulatory Filings	2024-07-26	English
Pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, the audio recording of the earnings conference .... Regulatory Filings	2024-07-26	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-07-26	English
Appointment of SMP Regulatory Filings	2024-07-26	English
Change in directors of the Company. Regulatory Filings	2024-07-26	English
Outcome of the Board Meeting held on 26th July 2024 Regulatory Filings	2024-07-26	English
Change in Management Regulatory Filings	2024-07-26	English
Change in Director(s) Regulatory Filings	2024-07-26	English
Outcome of Board Meeting Regulatory Filings	2024-07-26	English
Newspaper publication of consolidated unaudited financial results for the quarter ended 30th June 2024 Regulatory Filings	2024-07-26	English
Copy of Newspaper Publication Regulatory Filings	2024-07-26	English
Investor Presentation dated 26th July, 2024 Regulatory Filings	2024-07-26	English
Press Release for quarter ended 30th June 2024 Regulatory Filings	2024-07-26	English
Investor Presentation Regulatory Filings	2024-07-26	English
Press Release for quarter ended 30th June 2024 Regulatory Filings	2024-07-26	English
Press Release Regulatory Filings	2024-07-26	English
Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended 30th June 2024 Regulatory Filings	2024-07-26	English
Financial Result Updates Regulatory Filings	2024-07-26	English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HDFC Mutual Fund Regulatory Filings	2024-07-26	English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein mention the schedule of Analyst/Institutional ... Regulatory Filings	2024-07-19	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-07-19	English
Please find enclosed Newspaper advertisement titled " Notice of 88th AGM to be held through Video Conference / Other Audio-Visual Means, Record date and Final Dividend published in the .... Regulatory Filings	2024-07-18	English
Copy of Newspaper Publication Regulatory Filings	2024-07-18	English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Regulatory Filings	2024-07-16	English
Updates Regulatory Filings	2024-07-16	English
Pleas find enclosed intimation pursuant to Regulation 74(5) of SEBI (DP) Regulations Regulatory Filings	2024-07-15	English
Updates Regulatory Filings	2024-07-15	English
USFDA inspection at Company''s manufacturing facility in Kurkumbh, Maharashtra, India Regulatory Filings	2024-07-13	English
Updates Regulatory Filings	2024-07-13	English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the schedule of Earnings .... Regulatory Filings	2024-07-12	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-07-12	English
Please find enclosed the intimation regarding issuance of letter of confirmation Regulatory Filings	2024-07-10	English
Loss of Share Certificates Regulatory Filings	2024-07-10	English
ESOP/ESOS/ESPS Regulatory Filings	2024-07-05	English
In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the Operations and Administrative Committee .... Regulatory Filings	2024-07-05	English
Board Meeting — CIPLA LIMITED has informed the Exchange about Board Meeting to be held on 26-Jul-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarter… Regulatory Filings	2024-07-04	English
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2024 ,inter alia, to consider and approve the unaudited standalone and consolidated .... Regulatory Filings	2024-07-04	English
Board Meeting — Financial Results Regulatory Filings	2024-07-04	English
Dissolution of wholly owned step-down subsidiary Regulatory Filings	2024-07-04	English
Updates Regulatory Filings	2024-07-04	English
Dissolution of Cipla Dibcare (Pty) Limited i.e. wholly owned step-down subsidiary of the Company Regulatory Filings	2024-06-28	English
Updates Regulatory Filings	2024-06-28	English
Update on USFDA inspection at Company''s manufacturing facility in Patalganga, Maharashtra, India Regulatory Filings	2024-06-25	English
Updates Regulatory Filings	2024-06-25	English
USFDA inspection at Company''s manufacturing facility in Goa, India Regulatory Filings	2024-06-21	English
Updates Regulatory Filings	2024-06-21	English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for BlackRock Inc Regulatory Filings	2024-06-21	English
Loss of Share Certificates Regulatory Filings	2024-06-19	English
Please find enclosed the intimation for loss of share certificates Regulatory Filings	2024-06-19	English
Loss of Share Certificates Regulatory Filings	2024-06-19	English
Press Release Regulatory Filings	2024-06-18	English
Press Release- Cipla EU to invest additional EUR 3 million in Ethris Regulatory Filings	2024-06-18	English
Please find enclosed the intimation for loss of share certificate Regulatory Filings	2024-06-13	English
Loss of Share Certificates Regulatory Filings	2024-06-13	English
Copy of Newspaper Publication Regulatory Filings	2024-06-11	English
Please find the newspaper publication Regulatory Filings	2024-06-11	English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-06-11	English
Updates Regulatory Filings	2024-06-11	English
In compliance with provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the Operations and Administrative Committee .... Regulatory Filings	2024-06-10	English
ESOP/ESOS/ESPS Regulatory Filings	2024-06-10	English
Loss of Share Certificates Regulatory Filings	2024-06-03	English
Please find enclosed the intimation for loss of share certificates Regulatory Filings	2024-06-03	English
Change in Senior Management Personnel Regulatory Filings	2024-05-31	English
Change in Management Regulatory Filings	2024-05-31	English
Loss of Share Certificates Regulatory Filings	2024-05-30	English
Please find the attached intimation of loss of share certificate Regulatory Filings	2024-05-30	English
Please find the attached Annual Secretarial Compliance Report for the Financial Year ended 31st March 2024 Regulatory Filings	2024-05-30	English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein mention the schedule of Analyst / .... Regulatory Filings	2024-05-28	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-05-28	English
Please find enclosed the intimation for loss of shares certificate Regulatory Filings	2024-05-22	English
Loss of Share Certificates Regulatory Filings	2024-05-22	English
Updates Regulatory Filings	2024-05-22	English
Cipla receives final approval for the generic version of Somatuline (R) Depot (Ianreotide) Injection Regulatory Filings	2024-05-22	English
Shareholders meeting Regulatory Filings	2024-05-17	English
Please find the attached Result of Postal Ballot and Scrutinizer''s report Regulatory Filings	2024-05-17	English
ESOP/ESOS/ESPS Regulatory Filings	2024-05-17	English
In compliance with the provisions of Regulation 30 (Listing Obligation and Disclosure Requirements) Regulations, 2015, we hereby notify that the Operations and Administrations Committee .... Regulatory Filings	2024-05-17	English
Acquisition Regulatory Filings	2024-05-15	English
Cipla Limited has entered into definitive agreements on 15th May, 2024 for further investment of upto INR 26 crores in Achira Labs Private Limited, associate company. Regulatory Filings	2024-05-15	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-05-15	English
We are enclosing herewith copy of the transcript of the Company''s Q4 FY24 earnings conference call dated 10th May 2024. Regulatory Filings	2024-05-15	English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Samina Hamied & Others Regulatory Filings	2024-05-15	English
Clarification w.r.t. sale of shares by the Promoter Group is enclosed. Regulatory Filings	2024-05-15	English
Updates Regulatory Filings	2024-05-15	English
Resignation of Senior Management Personnel Regulatory Filings	2024-05-14	English
Resignation Regulatory Filings	2024-05-14	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-05-10	English
Pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, the audio recording of the earnings conference .... Regulatory Filings	2024-05-10	English
Newspaper publication Regulatory Filings	2024-05-10	English
Copy of Newspaper Publication Regulatory Filings	2024-05-10	English
Record date for payment of final dividend for FY 2023-24 Regulatory Filings	2024-05-10	English
Record Date Regulatory Filings	2024-05-10	English
ESOP/ESOS/ESPS Regulatory Filings	2024-05-10	English
Grant of Stock options and employee stock appreciation rights Regulatory Filings	2024-05-10	English
Investor presentation for Q4 & FY24 financial results Regulatory Filings	2024-05-10	English
Investor Presentation Regulatory Filings	2024-05-10	English
Press Release for Q4 & FY24 financial results Regulatory Filings	2024-05-10	English
Press Release Regulatory Filings	2024-05-10	English
Appointment of Cost Auditor for FY 2024-25 Regulatory Filings	2024-05-10	English
Change in Auditors Regulatory Filings	2024-05-10	English
Change in Management Regulatory Filings	2024-05-10	English
Appointment of Senior Management Personnel Regulatory Filings	2024-05-10	English
Recommendation of Final dividend for FY 2023-2024 Regulatory Filings	2024-05-10	English
Dividend Updates Regulatory Filings	2024-05-10	English
Dividend Regulatory Filings	2024-05-10	English
Outcome of board meeting held on 10th May 2024 Regulatory Filings	2024-05-10	English
Please find enclosed the result dated 10th May 2024 Regulatory Filings	2024-05-10	English
Financial Result Updates Regulatory Filings	2024-05-10	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-05-09	English
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company will hold one-on-one or .... Regulatory Filings	2024-05-09	English
USFDA inspection at Company''s manufacturing facility in Kurkumbh, Maharashtra, India. Regulatory Filings	2024-05-08	English
Updates Regulatory Filings	2024-05-08	English
Disclosure under SEBI Takeover Regulations Regulatory Filings	2024-05-07	English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-05-01	English
Updates Regulatory Filings	2024-05-01	English
Updates Regulatory Filings	2024-04-30	English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Regulatory Filings	2024-04-30	English
Updates Regulatory Filings	2024-04-29	English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-04-29	English
Updates Regulatory Filings	2024-04-26	English
Update on purchase of business undertaking on a slump sale arrangement from Ivia Beaute Private Limited, India.. Regulatory Filings	2024-04-26	English
Loss of Share Certificates Regulatory Filings	2024-04-20	English
Intimation regarding issuance of letter of confirmation under Regulation 39(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-04-20	English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-04-19	English
Updates Regulatory Filings	2024-04-19	English
Please find enclosed the Certificate from a PCS in compliance with Regulation 40(9) of the SEBI (LODR) Regulations, 2015 Regulatory Filings	2024-04-19	English
In compliance with regulation 30 of Listing Regulations, we had submitted the Notice of Postal Ballot dated 11th April 2024 on 16th April 2024 with the BSE. We noted that due to technical .... Regulatory Filings	2024-04-18	English
Copy of Newspaper Publication Regulatory Filings	2024-04-17	English
Please find the attached newspaper publication. Regulatory Filings	2024-04-17	English
Compliance certificate under Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-04-17	English
Certificate under Regulation 74(5) of SEBI (Depositories Participant) Regulations, 2018 Regulatory Filings	2024-04-17	English
Updates Regulatory Filings	2024-04-17	English
Shareholders meeting Regulatory Filings	2024-04-16	English
ESOP/ESOS/ESPS Regulatory Filings	2024-04-16	English
In compliance with the provisions of Regulation 30 (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby notify that the Operations and Administrative Committee .... Regulatory Filings	2024-04-16	English
Acquisition Regulatory Filings	2024-04-15	English
Acquisition of a business undertaking from Ivia Beaute Private Limited, India Regulatory Filings	2024-04-15	English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the schedule of Earnings .... Regulatory Filings	2024-04-05	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-04-05	English
Board Meeting — CIPLA LIMITED has informed the Exchange about Board Meeting to be held on 10-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended… Regulatory Filings	2024-04-05	English
Board Meeting — Financial Results/Dividend Regulatory Filings	2024-04-05	English
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 ,inter alia, to consider and approve 1. Consider and approve the Standalone .... Regulatory Filings	2024-04-05	English
Updates Regulatory Filings	2024-04-04	English
USFDA inspection at Company''s manufacturing facility in Patalganga, Maharashtra, India Regulatory Filings	2024-04-04	English
Change in Management Regulatory Filings	2024-03-26	English
Pursuant to Regulation 30 of the SEBI Listing Regulations, we hereby notify that Mr. Rajeev Kumar Sinha, presently working as Global Head - Formulations Manufacturing, has been appointed .... Regulatory Filings	2024-03-26	English
Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in India Regulatory Filings	2024-03-26	English
Press Release Regulatory Filings	2024-03-26	English
Merger of Cipla Technologies LLC, USA with Cipla USA Inc., USA, wholly owned step down subsidiaries of the Company Regulatory Filings	2024-03-26	English
Amalgamation/Merger Regulatory Filings	2024-03-26	English
Updates Regulatory Filings	2024-03-20	English
Intimation under Regulation 30 of SEBI Listing Regulation. Regulatory Filings	2024-03-20	English
Change in Management Regulatory Filings	2024-03-15	English
Further to the intimation filed on 15th March 2024, with respect to appointment of Mr. Venkata Sai Mungara as Senior Management Personnel and Global Head - Supply Chain of the Company, .... Regulatory Filings	2024-03-15	English
Change in Management Regulatory Filings	2024-03-15	English
Mr. Sai Venkata Mungara, presently working as Vice-president and Head Regional Supply Chain, North America has been appointed as Senior Management Personnel and Global Head - Supply Chain .... Regulatory Filings	2024-03-15	English
In compliance with the provisions of Regulation 30 (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby notify that the Operations and Administrative Committee .... Regulatory Filings	2024-03-15	English
ESOP/ESOS/ESPS Regulatory Filings	2024-03-15	English
We hereby notify that Goldencross Pharma Limited, wholly owned subsidiary of the Company has completed the sale of its entire shareholding in Wellthy Therapeutics Private Limited, in terms .... Regulatory Filings	2024-03-06	English
Updates Regulatory Filings	2024-03-06	English
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company will hold one-on-one / .... Regulatory Filings	2024-03-06	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-03-06	English
Updates Regulatory Filings	2024-03-06	English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-03-06	English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein mention the schedule of Analyst / .... Regulatory Filings	2024-03-05	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-03-05	English
Update on transfer of Generics Business Undertaking of the Company to Cipla Pharma and Life Sciences Limited, wholly owned subsidiary of the Company Regulatory Filings	2024-03-01	English
Updates Regulatory Filings	2024-03-01	English
Update on incorporation of a joint venture company in USA Regulatory Filings	2024-03-01	English
Updates Regulatory Filings	2024-03-01	English
Updates Regulatory Filings	2024-03-01	English
USFDA inspection at manufacturing facility in Qidong, Jiangsu Province, China Regulatory Filings	2024-03-01	English
Pursuant to Regulation 39(3) and other applicable regulations of the SEBI (listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Registrar .... Regulatory Filings	2024-03-01	English
Loss of Share Certificates Regulatory Filings	2024-03-01	English
ESOP/ESOS/ESPS Regulatory Filings	2024-02-16	English
In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the Operations and Administrative Committee .... Regulatory Filings	2024-02-16	English
Loss of Share Certificates Regulatory Filings	2024-02-13	English
Intimation regarding issuance of Letter of Confirmation under Regulation 39(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 ("Listing Regulation"). Regulatory Filings	2024-02-13	English
In furtherance to our intimation dated 1st December 2023 with respect to our participation at the Nuvama India Conference 2024, the presentation to be discussed at the conference is enclosed .... Regulatory Filings	2024-02-13	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-02-13	English
Update on acquisition of Actor Pharma (Pty) Ltd., South Africa Regulatory Filings	2024-02-07	English
Updates Regulatory Filings	2024-02-07	English
Further to our intimation dated 14th December, 2023, we hereby notify that closing conditions stated in definitive agreements signed by the Company on 14th December, 2023 have been met .... Regulatory Filings	2024-02-02	English
Updates Regulatory Filings	2024-02-02	English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-01-31	English
Updates Regulatory Filings	2024-01-31	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-01-29	English
We are enclosing herewith copy of the transcript of the Company''s Q3FY24 earnings conference call dated 25th January 2024. Regulatory Filings	2024-01-29	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-01-25	English
Pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, the audio recording of the earnings conference .... Regulatory Filings	2024-01-25	English
Change in Director(s) Regulatory Filings	2024-01-25	English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as enclosed. Regulatory Filings	2024-01-25	English
Appointment Regulatory Filings	2024-01-25	English
Acquisition Regulatory Filings	2024-01-23	English
Cipla (EU) Limited, UK and Cipla Holding BV, Netherlands, wholly owned subsidiaries of the Company have jointly incorporated ''Mexicip S.A.de C.V.'', a wholly owned subsidiary in Mexico .... Regulatory Filings	2024-01-23	English
Please find the enclosed investor presentation for Q3FY24 unaudited financial result. Regulatory Filings	2024-01-22	English
Investor Presentation Regulatory Filings	2024-01-22	English
Please find the attached enclosed the press release dated 22nd January 2024. Regulatory Filings	2024-01-22	English
Press Release Regulatory Filings	2024-01-22	English
Please find the attached extract of the consolidated unaudited financial results for the quarter ended 31st December 2023 to be published in newspaper. Regulatory Filings	2024-01-22	English
Copy of Newspaper Publication Regulatory Filings	2024-01-22	English
Please find the attached Unaudited financial results. Regulatory Filings	2024-01-22	English
Outcome of Board Meeting Regulatory Filings	2024-01-22	English
The Board of Directors of the company at its meeting held on 22nd December 2023, has approved unaudited consolidated and standalone financial results. Regulatory Filings	2024-01-22	English
Financial Result Updates Regulatory Filings	2024-01-22	English
We hereby notify that in compliance with Regulation 39(3) of the SEBI listing regulations read with SEBI circular dated 25th January 2022, the Company has approved the issuance of "Letter .... Regulatory Filings	2024-01-21	English
Loss of Share Certificates Regulatory Filings	2024-01-21	English
Board Meeting — CIPLA LIMITED has informed the Exchange about Board Meeting to be held on 22-Jan-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarter… Regulatory Filings	2024-01-21	English
The Board Meeting to be held on 25/01/2024 has been revised to 22/01/2024 The Board Meeting to be held on 25/01/2024 has been revised to 22/01/2024 Regulatory Filings	2024-01-20	English
Board Meeting — Financial Results Regulatory Filings	2024-01-20	English
Updates Regulatory Filings	2024-01-20	English
Intimation under regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is enclosed herewith. Regulatory Filings	2024-01-20	English
ESOP/ESOS/ESPS Regulatory Filings	2024-01-18	English
In compliance with the provisions of Regulation 30 (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby notify that the Operations and Administrative Committee .... Regulatory Filings	2024-01-18	English
Pursuant to regulation 74(5) of SEBI (DP) regulations, 2018, we enclose herewith a copy of the certificate received from Kfin Technologies Limited, the Registrar and Share Transfer Agent .... Regulatory Filings	2024-01-15	English
Certificate under SEBI (Depositories and Participants) Regulations, 2018 Regulatory Filings	2024-01-15	English
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the schedule of Earnings .... Regulatory Filings	2024-01-09	English
Analysts/Institutional Investor Meet/Con. Call Updates Regulatory Filings	2024-01-09	English
Cipla announces joint venture in the United States with Kemwell Biopharma and Manipal Education & Medical Group for global development and commercialisation of innovative cell therapy products Regulatory Filings	2024-01-08	English
Press Release Regulatory Filings	2024-01-08	English
Updates Regulatory Filings	2024-01-07	English
Acquisition Regulatory Filings	2024-01-07	English
Update on the Definitive Agreement entered between Cipla Technologies LLC and Pulmatrix Inc. for development and commercialization of Pulmazole Regulatory Filings	2024-01-06	English
Acquisition Regulatory Filings	2024-01-06	English
Cipla (EU) Limited, wholly owned subsidiary of the Company in UK, has entered into a joint venture agreement with Kemwell Biopharma UK Limited and MNI Ventures, Mauritius on 5th January, .... Regulatory Filings	2024-01-05	English
Board Meeting — CIPLA LIMITED has informed the Exchange about Board Meeting to be held on 25-Jan-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period e… Regulatory Filings	2024-01-03	English
Board Meeting — Financial Results Regulatory Filings	2024-01-03	English
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2024 ,inter alia, to consider and approve Pursuant to regulation 29 of listing .... Regulatory Filings	2024-01-03	English
ESOP/ESOS/ESPS Regulatory Filings	2024-01-02	English
In compliance with the provisions of Regulation 30 of SEBI Listing Regulations, 2015, we hereby notify that the operations and administrative committee of the company on 2nd January 2024, .... Regulatory Filings	2024-01-02	English
Updates Regulatory Filings	2024-01-02	English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Filings	2024-01-02	English

Filings by year

2026 86 filings
2025 246 filings
2024 327 filings
2023 271 filings
2022 275 filings
2021 302 filings
2020 301 filings
2019 258 filings
2018 110 filings
2017 103 filings
2016 123 filings
2015 84 filings
2014 52 filings
2013 39 filings
2012 5 filings
2011 5 filings
2010 1 filing